This review aims to summarize the interconnected alterations of the gut microbiota and the ENS in ASD, with a particular focus on the microbiota‐derived mediators that are altered in ASD, among patients and animal models, and that may affect ENS development and function.
Abstract
Autism spectrum disorder (ASD) is a neurodevelopmental disorder characterized by impairments in social interaction, restricted interests, and repetitive behaviors. In addition to these core behavioral symptoms, gastrointestinal (GI) disorders are frequently reported, ranging from severe constipation to diarrhea. The links between ASD and gut dysfunction are further supported by alterations in gut microbiota composition and in bacteria‐derived metabolites. As the intrinsic nervous system of the digestive tract, the enteric nervous system (ENS) plays a central role in gut physiology by exerting neuronal control on several gut functions, including motility. Located at the interface between the gut microbiota and intestinal function, the ENS may play a key role in the GI symptoms associated with ASD, as demonstrated in several mouse models. This review aims to summarize the interconnected alterations of the gut microbiota and the ENS in ASD, with a particular focus on the microbiota‐derived mediators that are altered in ASD, among patients and animal models, and that may affect ENS development and function. By highlighting these interactions, this review seeks to provide new insights on the digestive pathophysiology of ASD, which may also contribute to the severity of behavioral symptoms.
Intervention strategies targeting the gut microbiota-such as probiotics/prebiotics supplementation, fecal microbiota transplantation (FMT), and gluten-free/casein-free diets-show promise in alleviating gastrointestinal symptoms and core behavioral deficits in children with ASD.
Song-Qiu Qin, Yuan Lin, Yi-Meng Chen et al.· Frontiers in Microbiology· 1 citation
The interaction between gut microbiota and neuroinflammation in ASD is reviewed to provide insights for treatment and research, aiming to provide insights for treatment and research.
Cong Hu, He-Li Li, Yun-Jie Li et al.· Current Neuropharmacology· 0 citations
This review synthesizes current findings on the interplay among dietary patterns, gut microbiota dysbiosis, intestinal barrier dysfunction, and neuroimmune activation in ASD and evaluates microbiota-targeted interventions, including probiotics and fecal microbiota transplantation, as potential therapeutic strategies.
Fei Fan, Bo Wang, Fei Han· Frontiers in Psychiatry· 0 citations
This review summarizes current evidence on alterations in the gut microbiota in ASD and critically examines whether these changes contribute to disease pathogenesis or represent secondary effects, and highlights recent advances in multi-kingdom microbiome profiling, metabolomics, mechanistic studies of neuro inflammati...
Ahmed Kabrah, Saad Alghamdi, Anmar A. Khan et al.· Journal of Disability Resear...· 0 citations
The authors analyze GBA dysfunction across major DGBIs subtypes (irritable bowel syndrome, functional dyspepsia, and functional abdominal pain syndrome), highlighting microbiota dysbiosis, barrier dysfunction, and central sensitization.
Cong Yu, Xiu-Juan Wang, Shu-Zhu Chen· The Turkish Journal of Gastr...· 0 citations
The contribution of five major bacterial phyla associated with the mechanisms of systemic inflammation in ADHD are discussed: Actinomycetota, Bacillota, Bacteroidota, Pseudomonadota, Pseudomonadota, and Verrucomicrobiota.
R. F. Gasanov, D. Emelina, I. V. Kravchenko et al.· V.M. BEKHTEREV REVIEW OF PSY...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.